Carboplatin

Overview

Carboplatin is a chemotherapy medication used to treat various types of cancer. It is a platinum-based compound that interferes with the DNA of cancer cells, inhibiting their growth and division.

API suppliers (22)

Suppliers of Carboplatin backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• HERAEUS PRECIOUS METALS GMBH AND CO KG1 active DMF
• VERANOVA LP1 active DMF
• TAPI NL BV1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• HERAEUS PRECIOUS METALS GMBH AND CO KG1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• TAPI NL BV1 active DMF
• Qilu Pharmaceutical Co., Ltd.China1 active DMF
• HERAEUS PRECIOUS METALS GMBH AND CO KG1 active DMF
• Laurus Labs LimitedIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF
• TAPI NL BV1 active DMF
• Laurus Labs LimitedIndia1 active DMF
• Qilu Pharmaceutical Co., Ltd.China1 active DMF
• LACHEMA BRNO
• PLIVA-LACHEMA AS
• INSTITUTE DRUG TECHNOLOGY AUSTRALIA LTD
• Cipla USA, Inc.USA
• MAC CHEM PRODUCTS INDIA PVT LTD
• FRESENIUS KABI ONCOLOGY LTD

Patent & exclusivity (US)

Per the FDA Orange Book (47 approved US products), the latest listed US patent on Carboplatin expires 31 Mar 2045. Generic API sourcing typically opens up once these lapse.

Therapeutic areas